Acceleron Pharma Inc. (XLRN) is a clinical-stage biopharmaceutical company with a very bullish chart. Let's check it out.
More from Stocks
My investment conclusion and strategy is to sell in June for the anticipated market swoon.
A combination of behavioral and financial goals will help you produce exceptional results.
This is a market being driven by themes and stock-picking much more than the indices right now.